Contents
Issue 146 • September 2024
In association with
In Depth
Pharma casts a wide net to hook opportunities in metabolic disorders
Alzheimer’s: drug delivery and the blood brain barrier conundrum
Era of ADCs: pharma companies innovate to stand out in a buzzing market
AbbVie’s Humira loss of exclusivity has been a missed opportunity for competitors
How NVIDIA grew with the healthcare market instead of pushing into it